We are live on ! Find out more
CLAR icon

Clarus

94 hedge funds and large institutions have $280M invested in Clarus in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 49 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

30% more capital inflows, than outflows

Capital inflows: $31.9M | Capital outflows: $24.5M

6% more funds holding

Funds holding: 89 → 94 (+5)

1.78% more ownership

Funds ownership: 64.52% → 66.3% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

47% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 49

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.89%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
26
Reduced
49
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CLAR Hedge Fund Activity: Q3 2020 in Review

94 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Clarus (CLAR) for Q3 2020, worth a combined $280M — up 26% from $222M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CLAR positions and 7 closed out — a net gain of 5 holders — while 26 added to existing stakes and 49 trimmed.

The largest buyer was Brown Advisory, adding an estimated $7.76M. The largest seller was Kennedy Capital Management, cutting an estimated $6.88M.

  • 94 institutional investors held Clarus (CLAR) as of Q3 2020, up from 89 in Q2 2020.
  • Funds reported $280M of Clarus stock for Q3 2020, up 26% quarter-over-quarter.
  • 12 funds opened new Clarus positions in Q3 2020 and 7 closed out, a net change of +5 holders.
  • The largest Clarus buyer in Q3 2020 was Brown Advisory, an estimated $7.76M added.
  • The largest Clarus seller in Q3 2020 was Kennedy Capital Management, an estimated $6.88M sold.

Based on aggregated 13F filings for Q3 2020.